Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Eflornithine in Patients at High Risk of Colorectal Cancer
NCT00983580Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2009
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eflornithine, aspirin in adenomatous polyp, sponsored by National Cancer Institute. Started Aug 2009; status: completed.
02
Drugs
eflornithineaspirin
03
Conditions
adenomatous polyp
Beyond the preview
Go deeper on NCT00983580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983580.